Gilat Receives $9 Million Order for Defense SATCOM Solutions from Israel’s Ministry of Defense

(NASDAQ:GILT),(TASE:GILT.TA), Gilat Defense will deliver advanced modems to support and scale secure, mission-critical satellite communications for defense operations PETAH TIKVA, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that its defense division, Gilat Defense, has been […]

Applitools Strengthens Leadership Team to Drive Next Phase of Growth

COVINA, Calif. and TEL AVIV, Israel , Feb. 17, 2026 (GLOBE NEWSWIRE) — Applitools, the industry leader in AI-powered quality engineering and visual testing, today announced the expansion of its leadership team with the appointments of Joanna Schloss as Chief Marketing Officer, Kunal Rao as Chief Customer Officer, and Cam Sullivan as Senior Director of

Applitools Strengthens Leadership Team to Drive Next Phase of Growth

Applitools Strengthens Leadership Team to Drive Next Phase of Growth Strategic new hires to advance innovation, customer impact, and market leadership in AI-powered quality engineering and visual testing GlobeNewswire February 17, 2026 COVINA, Calif. and TEL AVIV, Israel , Feb. 17, 2026 (GLOBE NEWSWIRE) — Applitools, the industry leader in AI-powered quality engineering and visual

Gilat Receives $9 Million Order for Defense SATCOM Solutions from Israel’s Ministry of Defense

Gilat Receives $9 Million Order for Defense SATCOM Solutions from Israel's Ministry of Defense GlobeNewswire February 17, 2026 Gilat Defense will deliver advanced modems to support and scale secure, mission-critical satellite communications for defense operations PETAH TIKVA, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader

Bridging Continents and Capital: How ADIS26 Connects Africa’s Innovators with Silicon Valley

Santa Clara, California, Feb. 17, 2026 (GLOBE NEWSWIRE) — At a defining moment for Africa's economic and innovation landscape, the African Diaspora Network (ADN) will once again bring the world's most influential changemakers to Silicon Valley for the 2026 African Diaspora Investment Symposium (ADIS26) — March 25-27, 2026, at Santa Clara University. More than an

Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

(NASDAQ:KTTA),(NASDAQ:KTTAW), – Virtual presentation scheduled for Thursday, February 26, 2026, at 4:00 PM ET –– Webcast may be accessed here – MIAMI, Feb. 17, 2026 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic oral MEK inhibitor for the treatment of NF1-associated plexiform

Spot Pet Insurance Reaches One Million Customers Nationwide

Milestone highlights rising demand for predictable pet healthcare costs and faster access to veterinary care Spot Pet Insurance today announced it has surpassed one million customers nationwide, marking a major milestone in the company's growth and reflecting a broader shift in how pet parents manage the rising cost of veterinary care. Since launching, Spot has

Bridging Continents and Capital: How ADIS26 Connects Africa’s Innovators with Silicon Valley

Bridging Continents and Capital: How ADIS26 Connects Africa's Innovators with Silicon Valley GlobeNewswire February 17, 2026 Santa Clara, California, Feb. 17, 2026 (GLOBE NEWSWIRE) — At a defining moment for Africa's economic and innovation landscape, the African Diaspora Network (ADN) will once again bring the world's most influential changemakers to Silicon Valley for the 2026

Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference GlobeNewswire February 17, 2026 – Virtual presentation scheduled for Thursday, February 26, 2026, at 4:00 PM ET –– Webcast may be accessed here – MIAMI, Feb. 17, 2026 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a clinical-stage

Scroll to Top